Gene Fusions Found in Pancreatic, Biliary IOPNs
Patterns of genetic alterations could guide management.
Gastrointestinal Cancer
Gastrointestinal Cancer News & Features
Zejula Approved for Late-line Treatment of Recurrent Ovarian Cancer
Zejula, a poly(ADP-ribose) polymerase (PARP) inhibitor, is also approved for maintenance treatment in adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Preoperative Cachexia Predicts Poor Outcomes in Young Rather Than Elderly Gastric Cancer Patients: A Prospective Study
Background: Cachexia affects nearly 50–80% of cancer patients, and most studies have only focused on elderly patients. We investigated preoperative cachexia in gastric cancer (GC) patients by age group and comprehensively analyzed the impact of preoperative cachexia on the prognosis of GC patients in all age groups.Methods: In total, 575 patients were prospectively analyzed. The effect of…
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Gastrointestinal Cancer Clinical Trials
Clinical Trial: Biomarker Analysis of Gastrointestinal Cancer
Clinical Trial: Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment (Neoimmune)
Clinical Trial: S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Clinical Trial: Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer
Clinical Trial:Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Want to read more?
Please login or register first to view this content.